After provocation, the patients were treated with bromocriptine 2.5 mg twice a day for two weeks from the day of menstruation or withdrawal bleeding.

• 本研究以46位正泌乳激素、正促性腺激素排卵障碍不孕妇女为研究对象、其中16位为无排卵周期症、12位有月经稀少症、18位为续发性无月经症。